Latest Whitepapers
Whitepaper
Transforming Cancer Drug Discovery With Comprehensive Tumor Models
This whitepaper explores groundbreaking organ-on-a-chip technology and 3D tissue modeling that is closing the translational gap in cancer drug discovery.
Whitepaper
Empowering CRISPR With Innovative Single Cell Isolation
This whitepaper explores the advantages of a novel cell sorting and dispensing platform – which combines microfluidics, flow cytometry and liquid dispensing – that can help researchers get to their optimal clones more efficiently.
Whitepaper
Understanding Cell-to-Cell Communication in Cancer
This article explores how we can find new ways to stop tumor growth and prevent drug resistance by targeting the language of cancer cell communication.
Whitepaper
How To Choose the Right Assay for PARP
When assessing PARP enzymatic activity for drug development, each component must be carefully optimized to ensure sensitivity, robustness and reproducibility. This whitepaper explores methods and reagents available to evaluate drug specificity and effectiveness.
Whitepaper
Quantitative Assays To Accelerate Therapeutic Antibody Development
This whitepaper explores the tools available to characterize antibody binding to Fc receptors, including quantitative assays to support optimization of therapeutic products.
Whitepaper
Real-Time Metabolic Analysis for Cancer Research
This brochure explores the applications of a real-time metabolic analysis platform for cancer research and cell therapeutics development.
Whitepaper
Multiomic Sequencing Solutions To Revolutionize Human Disease Research
Understanding the mechanisms of human disease requires a multiomic approach; however, legacy multiomic methods require multiple platforms and complex processes with lengthy turnaround times and considerable costs.
Whitepaper
Advances in Cell Therapy
This article examines recent advancements in cell therapy research, from promising lab findings poised for clinical translation to enhancements in development, testing, and manufacturing processes.
Whitepaper
Enhancing Immune Cell Cytotoxicity and Persistence Insights Using Real-Time Cell Analysis
Cell therapies, from regenerative medicine to immunotherapy, are transforming the medical landscape with 75 already approved globally and over 2,000 in development.
Whitepaper
Improving Cancer Patient Care With Professor Mark Lawler
In this article, Mark Lawler, professor of digital health, answers your questions about these revolutionary techniques and discusses the barriers to their implementation in the clinic. Prof. Lawler has an international reputation in cancer research and a focus on developing a molecular understanding of cancer to improve patient care, including through precision medicine.
Advertisement